Shasun Inks Pact With Danish Firm

Chennai: Shasun Chemicals & Drugs Ltd has said that its wholly owned UK subsidiary Shasun Pharma Solutions Ltd has forayed into a non-exclusive licensing agreement with H Lundbeck A/S, a research-based Danish company engaged in finding new drugs for treatment of CNS (Central Nervous System) disorders. As per the agreement, Shasun Pharma grants H Lundbeck A/S the use of its proprietary cross-coupling technology (also known as Buchwald technology) to manufacture and comme rcialise new APIs (active pharmaceutical ingredients).